BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Embryo
,
Early pregnancy factor
,
Tamoxifen
,
rs6983267
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
carbonic anhydrase- II
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Affymetrix]
Explore Curated Studies Results
Literature
Most Relevant Literature
Water networks in fast proton transfer during catalysis by human carbonic anhydrase II.
Spectroscopic characterization of furosemide binding to human carbonic anhydrase II.
Chemical rescue of enzymes: proton transfer in mutants of human carbonic anhydrase II.
Kinetic and crystallographic studies of the role of tyrosine 7 in the active site of human carbonic …
Structural and kinetic study of the extended active site for proton transfer in human carbonic anhyd…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyro…
IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study
Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer
Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ